BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28783468)

  • 1. Evaluation of Experimental Infection with L. ( L.) Amazonensis in X-Linked Immunodeficient Mice.
    Gonzaga WFKM; Geraldo MM; Vivanco BC; Popi AF; Mariano M; Batista WL; Xander P
    J Parasitol; 2017 Dec; 103(6):708-717. PubMed ID: 28783468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulating role of IL-10-producing B cells in Leishmania amazonensis infection.
    Firmino-Cruz L; Ramos TD; da Fonseca-Martins AM; Maciel-Oliveira D; Oliveira-Silva G; Pratti JES; Cavazzoni C; Chaves SP; Oliveira Gomes DC; Morrot A; Freire-de-Lima L; Vale AM; Freire-de-Lima CG; Decote-Ricardo D; de Matos Guedes HL
    Cell Immunol; 2018 Dec; 334():20-30. PubMed ID: 30170688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of signaling by IL-4 or by IL-4/IL-13 has more attenuating effects on Leishmania amazonensis dorsal skin--than on footpad-infected mice.
    Felizardo TC; Gaspar-Elsas MI; Lima GM; Abrahamsohn IA
    Exp Parasitol; 2012 Jan; 130(1):48-57. PubMed ID: 22019418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
    Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
    Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-1 cells contribute to susceptibility in experimental infection with Leishmania (Leishmania) chagasi.
    Gonzaga WF; Xavier V; Vivanco BC; Lopes JD; Xander P
    Parasitology; 2015 Oct; 142(12):1506-15. PubMed ID: 26416198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. X-linked immunodeficient mice exhibit enhanced susceptibility to Cryptococcus neoformans Infection.
    Szymczak WA; Davis MJ; Lundy SK; Dufaud C; Olszewski M; Pirofski LA
    mBio; 2013 Jul; 4(4):. PubMed ID: 23820392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hairless mice as an experimental model of infection with Leishmania (Leishmania) amazonensis.
    Araujo VC; Fukutani KF; Oshiro ET; Rodrigues PO; Rizk YS; Carollo CA; Arruda CC
    Exp Parasitol; 2015 Oct; 157():138-44. PubMed ID: 26234915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis.
    Padigel UM; Alexander J; Farrell JP
    J Immunol; 2003 Oct; 171(7):3705-10. PubMed ID: 14500669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory effect of Canova medication on experimental Leishmania amazonensis infection.
    Pereira WK; Lonardoni MV; Grespan R; Caparroz-Assef SM; Cuman RK; Bersani-Amado CA
    J Infect; 2005 Aug; 51(2):157-64. PubMed ID: 16038768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan.
    Halliday A; Bates PA; Chance ML; Taylor MJ
    Parasit Vectors; 2016 Oct; 9(1):532. PubMed ID: 27716391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The histopathological and immunological pattern of CBA mice infected with Leishmania amazonensis after treatment with pyrazole carbohydrazide derivatives.
    Charret KS; Lagrota-Cândido J; Carvalho-Pinto CE; Hottz CF; Lira ML; Rodrigues RF; Gomes AO; Bernardino AM; Canto-Cavalheiro MM; Leon LL; Amaral VF
    Exp Parasitol; 2013 Feb; 133(2):201-10. PubMed ID: 23219949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depletion of peritoneal CD5+ B cells has no effect on the course of Leishmania major infection in susceptible and resistant mice.
    Babai B; Louzir H; Cazenave PA; Dellagi K
    Clin Exp Immunol; 1999 Jul; 117(1):123-9. PubMed ID: 10403925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmania amazonensis: participation of regulatory T and B cells in the in vitro priming (PIV) of CBA/J spleen cells susceptible response.
    Veras PS; Welby-Borges M; de Santana CD; Nihei J; Cardillo F; de Freitas LA
    Exp Parasitol; 2006 Jul; 113(3):201-5. PubMed ID: 16516200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of inflammation response to murine cutaneous Leishmaniasis by homeopathic medicines: Antimonium crudum 30cH.
    Rodrigues de Santana F; de Paula Coelho C; Cardoso TN; Perez Hurtado EC; Roberti Benites N; Dalastra Laurenti M; Villano Bonamin L
    Homeopathy; 2014 Oct; 103(4):264-74. PubMed ID: 25439043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-1 lymphocytes are able to produce IL-10, but is not pathogenic during Leishmania (Leishmania) amazonensis infection.
    Firmino-Cruz L; Ramos TD; da Fonseca-Martins AM; Oliveira-Maciel D; Oliveira-Silva G; Dos Santos JS; Cavazzoni C; Morrot A; Gomes DCO; Vale AM; Decoté-Ricardo D; Freire-de-Lima CG; de Matos Guedes HL
    Immunobiology; 2020 Jan; 225(1):151857. PubMed ID: 31744626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Xid defect determines an improved clinical course of murine leishmaniasis in susceptible mice.
    Hoerauf A; Solbach W; Lohoff M; Röllinghoff M
    Int Immunol; 1994 Aug; 6(8):1117-24. PubMed ID: 7981141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection.
    Jones DE; Buxbaum LU; Scott P
    J Immunol; 2000 Jul; 165(1):364-72. PubMed ID: 10861073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of interleukin-4 and prostaglandin E2 in Leishmania amazonensis infection of BALB/c mice.
    Guimarães ET; Santos LA; Ribeiro dos Santos R; Teixeira MM; dos Santos WL; Soares MB
    Microbes Infect; 2006 Apr; 8(5):1219-26. PubMed ID: 16531090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leishmania pifanoi pathogenesis: selective lack of a local cutaneous response in the absence of circulating antibody.
    Colmenares M; Constant SL; Kima PE; McMahon-Pratt D
    Infect Immun; 2002 Dec; 70(12):6597-605. PubMed ID: 12438331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of TLR9 on Leishmania amazonensis infection and its influence on intranasal LaAg vaccine efficacy.
    Pratti JES; da Fonseca Martins AM; da Silva JP; Ramos TD; Pereira JC; Firmino-Cruz L; Oliveira-Maciel D; Vieira TSS; Lacerda LL; Vale AM; Freire-de-Lima CG; Gomes DCO; Saraiva EM; Rossi-Bergmann B; de Matos Guedes HL
    PLoS Negl Trop Dis; 2019 Feb; 13(2):e0007146. PubMed ID: 30802247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.